Introduced
Committee
Markup
Reported
Floor
Passed
Enacted
HR.1463 119th Congress

To prohibit the use of Federal funds to implement, administer, or enforce a final rule of the Food and Drug Administration relating to "Medical Devices; Laboratory Developed Tests", and for other purposes.

Status
In Committee
Latest Action
2025-02-21
Sponsor
Finstad, Brad (R-Minnesota)
Official Source
Investability
42/100
Stage
COMMITTEE
Related Bills
0
Full Text
1,316 chars
Alive
Yes
GovGreed Synthesis ·
This bill prohibits the use of federal funds to implement, administer, or enforce the final rule issued by the Food and Drug Administration (FDA) titled Medical Devices; Laboratory Developed Tests and published on May 6, 2024, or any substantially similar rule. The rule specifies that laboratory developed tests (medical screening tests developed by laboratories rather than medical device manufacturers) are medical devices subject to FDA regulation with limited exceptions. Prior to the rule, the FDA had exercised discretion as to whether to apply regulations for medical devices to laboratory developed tests.
DGX
85% confidence
Blocks regulatory burden on LDTs core to lab testing business; Trump holds $1,001-$15,000 per get_executive_branch_exposure; net congressional buys (8 buys vs 4 sells, Khanna D and Letlow R buyers) per get_sector_political_positioning; $703M federal contracts (DoD, HHS etc., 498 contracts) per get_government_precedent
View DGX intelligence →
LH
80% confidence
Blocks regulatory burden on LDTs; Trump holds $1,001-$15,000 and < $1,001, Hegseth $1,001-$15,000 per get_executive_branch_exposure; strongest congressional positioning (37 buys vs 12 sells, Bresnahan R, Khanna D buyers, $590k buy max) per get_sector_political_positioning
View LH intelligence →

Top winners identified by GovGreed LLM analysis. Full impact map with all affected tickers available to Pro subscribers.

2025-02-21
Referred to the House Committee on Energy and Commerce.
2025-02-21
Introduced in House
2025-02-21
Introduced in House
119 HR 1463 IH: To prohibit the use of Federal funds to implement, administer, or enforce a final rule of the Food and Drug Administration relating to “Medical Devices; Laboratory Developed Tests”, and for other purposes. U.S. House of Representatives 2025-02-21 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. I 119th CONGRESS 1st Session H. R. 1463 IN THE HOUSE OF REPRESENTATIVES February 21, 2025 Mr. Finstad (for himself and Mr. Crenshaw ) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To prohibit the use of Federal funds to implement, administer, or enforce a final rule of the Food and Drug Administration relating to Medical Devices; Laboratory Developed Tests , and for other purposes. 1. Prohibition on funding for Food and Drug Administration rule relating to medical devices; laboratory developed tests Notwithstanding any other provision of law, no Federal funds may be used to implement, administer, or enforce the final rule of the Food and Drug Administration relating to Medical Devices; Laboratory Developed Tests that was submitted for publication in the Federal Register on May 6, 2024 (89 Fed. Reg. 37286), or any substantially similar rule.
🔒 GovGreed Pro · Trading Intelligence on HR.1463 Get Access — $24.50/mo
Loading intelligence layer…
Bill text sourced from GovInfo.gov · public domain · last updated recently.
Plain-English summary, score breakdown, and trading-intelligence panels are GovGreed-original analysis derived from STOCK Act filings, SEC Form 4 disclosures, FEC contributions, and Senate LDA lobbying reports — all publicly filed federal records.
GovGreed is not affiliated with the U.S. Government. Not financial advice.